Literature DB >> 29270482

Can acupuncture therapy help patients with retinitis-pigmentosa?

Firouzeh Fereydouni1, Vahid Qasemi2, Siamak Moradian3, SeyyedMehdi Tabatabaee1.   

Abstract

PURPOSE: To evaluate the effect of acupuncture therapy on visual function of patients with retinitis-pigmentosa (RP).
METHODS: In a prospective study, 23 RP subjects received ten sessions of body-acupuncture. Pre and post-treatment evaluations included best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), near visual acuity (NVA), and static 30-2 perimetry.
RESULTS: UCVA, BCVA, and NVA improvements after acupuncture therapy were statistically and clinically significant (P = 0.048, P = 0.0005, P = 0.002, respectively). The changes of mean foveal threshold (MFT) and mean deviation (MD) were statistically significant (P = 0.031, P = 0.02). There were no statistically significant difference between different age group and genders. Subjective symptoms of improvement were seen in most of cases.
CONCLUSION: Future studies are needed to show the effect of acupuncture therapy on visual function of patients with RP.

Entities:  

Keywords:  Acupuncture; Chinese medicine; Retina; Retinitis pigmentosa

Year:  2017        PMID: 29270482      PMCID: PMC5735244          DOI: 10.1016/j.joco.2017.07.004

Source DB:  PubMed          Journal:  J Curr Ophthalmol        ISSN: 2452-2325


Introduction

Retinitis-pigmentosa (RP) with a prevalence of one in 3000–5000 individuals,1, 2, 3, 4, 5, 6, 7 is a retinal dystrophy that leads to permanent visual dysfunction. Several treatment modalities have been evaluated, however, no treatment has proved useful.4, 8 Acupuncture is a convenient, effective, and simple part of traditional Chinese medicine that has few side effects. Acupuncture has been used to treat a wide variety of eye diseases.10, 11 Basic science, clinical research, and RP patients' self-reports support the hypothesis that acupuncture may improve visual function.1, 8, 10, 12, 13, 14, 15 The goal of this project was to determine whether it would support the hypothesis that visual function can improve after treatment with a standardized acupuncture protocol.

Methods

This was a prospective, interventional case series study of 23 RP subjects. Each subject received ten sessions of body acupuncture. Pre and post-treatment evaluations included best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), near visual acuity (NVA) (Bailey–Lovie chart), and Swedish Interactive Threshold Algorithm (SITA) standard static 30-2 perimetry (Humphrey perimeter). All patients were evaluated by an experienced retina specialist. The symptoms, signs, and electroretinogram (ERG) findings in the patients met the usual definitions of RP. The subjects had no previous history of acupuncture and BCVA better than 1 logMAR. Subjects discontinued taking any nutritional supplements, under the supervision of a specialist ophthalmologist, at least one month before the beginning of acupuncture sessions. An interview was conducted at the beginning of each post-treatment follow-up visit by a simple four-choice (no improvement, a little, moderate improvement, very) questionnaire to determine subjective changes in visual function (night, light, distance and near activities, and central and peripheral vision). Post-intervention evaluations were taken 7–10 days after the last session of acupuncture to eliminate the psychological effects of treatment. The acupuncture prescription was: Si Bai, Yin-Tang, Feng-Chi, Yu-Yao, Guang-Ming, Yang-Lao, Tai-Chong, Shen-Ting, Qu-Chi, Xue-Hai, Ganshu, Shenshu (Fig. 1). Informed consent was obtained.
Fig. 1

Acupuncture points for retinitis-pigmentosa (RP).

Acupuncture points for retinitis-pigmentosa (RP). Changes were considered significant clinically if any of the following improvements occurred relative to baseline measures: 0.1 logMAR for UCVA, BCVA, or NVA, changes greater than 5 db in foveal threshold (FT) and mean foveal threshold (MFT) or 2 db in mean deviation (MD) or pattern standard deviation (PSD) in perimetry. Statistical testing was carried out by using the SPSS-19. P-value ≤ 0.05 was considered statistically significant.

Results

UCVA and BCVA changes were statistically (P = 0.048, 0.0005) and clinically significant. The change in NVA was statistically significant (P = 0.002) (Table 1). There were no statistically significant difference between different age groups (P = 0.434, P = 0.808, P = 0.175, respectively) and genders (P = 0.414, P = 0.640, P = 0.295, respectively).
Table 1

The distribution of mean difference, mean before treatment, mean after treatment, and P-value of uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), near visual acuity (NVA), mean foveal threshold (MFT), and mean deviation (MD) before and after acupuncture therapy.

Mean before treatmentMean after treatmentMean differenceVarianceP-value
UCVA1.046 ± 0.510.980 ± 0.520.029 ± 0.0720.0440.048
BCVA0.630 ± 0.440.528 ± 0.420.069 ± 0.0910.230.0005
NVA0.535 ± 0.520.455 ± 0.480.061 ± 0.1140.020.007
MFT8.90 ± 8.859.87 ± 9.071.872 ± 8.65774.950.031
MD−30.31 ± 3.85−28.44 ± 10.181.872 ± 8.65774.950.02

UCVA: Uncorrected visual acuity; BCVA: Best corrected visual acuity; NVA: Near visual acuity; MFT: Mean foveal threshold; MD: Mean deviation.

The distribution of mean difference, mean before treatment, mean after treatment, and P-value of uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), near visual acuity (NVA), mean foveal threshold (MFT), and mean deviation (MD) before and after acupuncture therapy. UCVA: Uncorrected visual acuity; BCVA: Best corrected visual acuity; NVA: Near visual acuity; MFT: Mean foveal threshold; MD: Mean deviation. MFT and MD were statistically (P = 0.031, 0.02) significant but not clinically (Table 1). There were no statistically significant difference between different age groups (P = 0.301, P = 0.305, respectively) and the genders (P = 0.767, P = 0.377 respectively) (Table 1). PSD and FT were neither statistically nor clinically changed. Subjective changes are described in Table 2.
Table 2

The rate of subjective improvement after acupuncture therapy in retinitis-pigmentosa (RP) patients.

No improvementA littleModerate improvementVery
Night VA21.74%65.22%13.04%
Day VA8.696%69.57%21.74%
Distance VA17.39%52.17%26.09%4.348%
Near VA30.43%52.17%17.39%
Central VA21.74%60.87%17.39%
Peripheral VA8.696%52.17%34.78%4.348%

VA: Visual acuity.

The rate of subjective improvement after acupuncture therapy in retinitis-pigmentosa (RP) patients. VA: Visual acuity.

Discussion

In this study we found that the most robust improvements in visual function were for central vision, as we found changes in UCVA, BCVA, NVA, and MFT statistically significant, although the changes of MFT and NVA were not clinically significant. This finding was in agreement with previous studies.9, 10, 11 Results have been shown that acupuncture therapy has subjective satisfaction with itself, for patients with RP. Recent studies demonstrated acupuncture can elicit activity in specific brain areas.16, 17 These specific cerebral activation patterns might explain the therapeutic effects of acupuncture in certain subjects. Regardless of the diagnosis, incurable retinal diseases respond favorably to acupuncture. This study has several limitations including small sample size, the lack of sample group, lack of investigation of RP genotypes, and the durability of treatment effect. The effectiveness of the other body acupuncture prescriptions, auricular acupuncture, mixed acupuncture or electro acupuncture (EA) and also the effect of different needle materials should be further explored in future research. In conclusion future studies are needed to show the effect of acupuncture therapy on visual function of patients with RP.
  15 in total

1.  Functional MRI in healthy subjects during acupuncture: different effects of needle rotation in real and false acupoints.

Authors:  J L Fang; T Krings; J Weidemann; I G Meister; A Thron
Journal:  Neuroradiology       Date:  2004-04-22       Impact factor: 2.804

2.  Laser acupuncture induced specific cerebral cortical and subcortical activations in humans.

Authors:  Christian M Siedentopf; Florian Koppelstaetter; Ilka Anna Haala; Veronika Haid; Paul Rhomberg; Anja Ischebeck; Waltraud Buchberger; Stephan Felber; Andreas Schlager; Stefan M Golaszewski
Journal:  Lasers Med Sci       Date:  2005-07-01       Impact factor: 3.161

3.  Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa.

Authors:  Volker Busskamp; Jens Duebel; David Balya; Mathias Fradot; Tim James Viney; Sandra Siegert; Anna C Groner; Erik Cabuy; Valérie Forster; Mathias Seeliger; Martin Biel; Peter Humphries; Michel Paques; Saddek Mohand-Said; Didier Trono; Karl Deisseroth; José A Sahel; Serge Picaud; Botond Roska
Journal:  Science       Date:  2010-06-24       Impact factor: 47.728

4.  Role of acupuncture in the treatment of 'incurable' retinal diseases.

Authors:  N S Reddy; N M Fouzdar
Journal:  Indian J Ophthalmol       Date:  1983       Impact factor: 1.848

5.  The use of acupuncture in ophthalmology.

Authors:  S Wong; R Ching
Journal:  Am J Chin Med       Date:  1980 Spring-Summer       Impact factor: 4.667

6.  Genetic and epidemiological investigations on pigmentary degeneration of the retina and allied disorders in Switzerland.

Authors:  F Ammann; D Klein; A Franceschetti
Journal:  J Neurol Sci       Date:  1965 Mar-Apr       Impact factor: 3.181

7.  Epidemiology of retinitis pigmentosa in Denmark.

Authors:  Marianne Haim
Journal:  Acta Ophthalmol Scand Suppl       Date:  2002

8.  Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa.

Authors:  J Gong; B Rosner; D G Rees; E L Berson; C A Weigel-DiFranco; E J Schaefer
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-08       Impact factor: 4.799

9.  Population genetic studies of retinitis pigmentosa.

Authors:  J A Boughman; P M Conneally; W E Nance
Journal:  Am J Hum Genet       Date:  1980-03       Impact factor: 11.025

10.  How to design the control group in randomized controlled trials of acupuncture?

Authors:  Jaung-Geng Lin; Chao-Hsun Chen; Yu-Che Huang; Yi-Hung Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.